US Broker Ratings

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Navigating Growth with a Potential 4.28% Upside

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a notable player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $19.51 billion, Zimmer Biomet..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Exploring a 9.86% Upside in the Diagnostics & Research Sector

Mettler-Toledo International, Inc. (NYSE: MTD), a leader in precision instruments and services, stands out in the healthcare sector, particularly within the diagnostics and research industry. Headquartered in Greifensee, Switzerland, the..

GSK plc (GSK) Stock Analysis: Navigating Growth Amid a 3% Dividend Yield and Robust ROE

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, continues to capture the attention of investors with its expansive portfolio and solid financial metrics. As a leading player in..

Veeva Systems Inc. (VEEV) Stock Analysis: Uncovering a 61% Potential Upside Opportunity

Veeva Systems Inc. (NYSE: VEEV), a leader in cloud-based solutions tailored for the life sciences sector, presents a compelling investment case for those seeking growth-oriented opportunities in the healthcare technology..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Evaluating the 11.3% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) stands as a titan in the biotechnology industry, with a formidable market cap of $82.64 billion. As a key player in the healthcare sector, Regeneron..

Quest Diagnostics (DGX) Stock Analysis: Navigating Growth Amidst a 2.58% Potential Upside

Quest Diagnostics Incorporated (NYSE: DGX), a prominent player in the healthcare sector, is a leading provider of diagnostic testing and services both in the United States and internationally. With a..

Koninklijke Philips N.V. (PHG) Stock Analysis: Exploring a 9.84% Upside in the Healthcare Sector

Koninklijke Philips N.V. (NYSE: PHG), a stalwart in the healthcare sector, offers a unique investment opportunity with a potential upside of 9.84% based on current analyst ratings. Headquartered in Amsterdam,..

Merck & Company, Inc. (MRK) Stock Analysis: Healthcare Titan with Strong Buy Ratings and Growth Potential

Merck & Company, Inc. (NYSE: MRK), a stalwart of the healthcare sector, has long been a beacon of innovation and success in the drug manufacturing industry. With a market capitalization..

Danaher Corporation (DHR) Stock Analysis: Exploring a 25.76% Potential Upside in the Healthcare Sector

Danaher Corporation (NYSE: DHR), a prominent player in the healthcare sector, commands significant attention from investors due to its robust market presence and diverse portfolio. With a market capitalization of..

Elevance Health, Inc. (ELV) Stock Analysis: Navigating a 21.20% Potential Upside in the Healthcare Sector

For investors seeking opportunities in the healthcare sector, Elevance Health, Inc. (ELV) presents an intriguing proposition. With a substantial market capitalization of $70.63 billion, this Indianapolis-based healthcare benefits company, formerly..

STERIS plc (STE) Stock Analysis: Assessing the 11.45% Potential Upside for Investors

Investors are always on the lookout for opportunities that offer both growth and stability. STERIS plc (NYSE: STE), a leader in the healthcare sector specializing in infection prevention products and..

Medtronic plc (MDT) Investor Outlook: Analyzing a 14.37% Upside Potential Amidst Strong Revenue Growth

For investors seeking robust opportunities in the healthcare sector, Medtronic plc (NYSE: MDT) presents a compelling case. With its headquarters in Galway, Ireland, Medtronic stands as a formidable entity in..

Zoetis Inc. (ZTS) Stock Analysis: Exploring a 15% Upside in the Animal Health Sector

Zoetis Inc. (ZTS), a key player in the healthcare sector, specifically in the drug manufacturing industry focusing on specialty and generic products, presents an intriguing opportunity for investors looking to..

Intuitive Surgical, Inc. (ISRG) Stock Analysis: Assessing 21% Potential Upside for Investors

Intuitive Surgical, Inc. (ISRG) stands at the forefront of the healthcare sector, specifically in the medical instruments & supplies industry. With a commanding market capitalization of $178.81 billion, it represents..

Edwards Lifesciences (EW) Stock Analysis: Evaluating a Potential 11.56% Upside in the Healthcare Sector

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the medical devices industry, specializes in innovative solutions for treating advanced cardiovascular diseases. With a robust market capitalization of $50.77 billion,..

Bristol-Myers Squibb (BMY) Stock Analysis: A Healthcare Giant with a Solid 4.04% Dividend Yield

Bristol-Myers Squibb Company (NYSE: BMY), a stalwart in the healthcare sector, continues to capture investor interest with its robust dividend yield and diversified pharmaceutical portfolio. With a market capitalization of..

McKesson Corporation (MCK) Stock Analysis: Navigating Growth and Valuation in Healthcare Distribution

For investors keen on the healthcare sector, McKesson Corporation (NYSE: MCK) stands out as a titan in medical distribution with substantial market influence. With a market cap of $121.87 billion,..

UnitedHealth Group (UNH) Stock Report: Potential 24.33% Upside as Analysts Favor Buy

UnitedHealth Group Incorporated (NYSE: UNH), a prominent player in the healthcare sector, stands out with its robust market capitalization of $265.66 billion. As a leader in healthcare plans, the company..

The Cigna Group (CI) Stock Analysis: Exploring a 14.77% Upside Potential

Investors seeking opportunities within the healthcare sector might find The Cigna Group (NYSE: CI) an intriguing prospect. With a substantial market capitalization of $77.42 billion, Cigna stands as a formidable..

AstraZeneca PLC (AZN) Investor Outlook: Evaluating the Healthcare Giant Amidst a -21.01% Potential Downside

As a titan in the healthcare sector, AstraZeneca PLC (NASDAQ: AZN) commands a significant presence with a market capitalization of $323.16 billion. Known for its robust portfolio of prescription medicines..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds